Since several P2Y receptors have been shown to activate oncogenic EGFR signalling [18,19,20], we hypothesised that inhibition of P2Y12 may reduce epidermal growth factor receptor (EGFR) signalling and cancer growth. Here, EGFR is linked to cancer.